Dermatology Book

http://www.fpnotebook.com/

Eflornithine CreamAka: Vaniqa

Advertisement

  1. Indications
    1. Hirsutism: Removal of unwanted facial hair in women
  2. Pharmacology
    1. Irreversible inhibitor of ornithine decarboxylase
      1. Inhibits polyamine biosynthesis
      2. Decreases polyamine mediated cell division
    2. Prior systemic use for African Trypanosomiasis
    3. Peak systemic absorption <10 ng/ml
  3. Adverse Effects: Local irritation
    1. Stinging or burning
    2. Tingling
  4. Dosing (30 gram tube costs pharmacist $42)
    1. Apply thin layer to affected area bid
    2. Doses should be at least 8 hours apart
    3. Avoid washing area for 4 hours after application
  5. Efficacy
    1. Modestly effective in reducing unwanted facial hair
    2. Hair Growth recurs soon after stopping medication
  6. References
    1. (2000) Med Lett Drugs Ther 42(1089):96

Vaniqa (C0939525)

ConceptsOrganic Chemical (T109) , Pharmacologic Substance (T121)
MSHD000518
EnglishVaniqa, Women First Brand of Eflornithine Hydrochloride
SourcesMSH, NCI, RXNORM
Derived from the NIH UMLS (Unified Medical Language System)



Navigation Tree